In the US, Europe, Australia and Canada, 2014 biotech sales totaled $123.1 billion, rising 24.3%, with each country or region accounting for 76%, 19%, 5% and 0.2% of sales, respectively. Sales of Gilead Science’s hepatitis C drugs accounted for a sizable portion of revenues in 2014; adjusting for Gilead, growth for the industry was 12%. […]
By the University of Manchester’s estimates, $2.4 billion has been invested in graphene research. In 2014, Lux Research projected a 2025 global market of $349 million for the material; however, in 2013, sales of graphene totaled only $12 million. Manufacture of the material has accelerated, with total production capacity of graphene nanoplatelets in the Americas; […]
Based on the top 500 pharmaceutical and biotechnology companies, the 2020 global market for prescription drugs is forecast at $987 billion, with a compound annual growth rate (CAGR) of 4.8% from 2014 to 2020. Sales in 2014 grew to $743 billion, up 2.8%, and total R&D increased 3.1% to $141.6 billion. R&D is forecast to […]
Major US equity markets contracted roughly 2.0% or more on June 29 when Greece failed to reach an agreement with its international creditors. As a result, the country essentially defaulted on its $1.7 billion loan payment to the International Monetary Fund (IMF) the following day. While discussions are expected to continue, Greece no longer has […]
Mikkeli, Finland 6/1/15 and Helsinki, Finland 6/1/15—Private equity firm VersoVentures has acquired Environics, a supplier of industrial gas detection as well as chemical, biological, radiological and nuclear monitoring solutions, for an undisclosed amount. ”The gas detection market is estimated to grow, driven by increased demands in personnel safety, environmental protection and process efficiency,” commented Anssi […]
Wellesley, MA and Tucson, AZ 6/18/15—Ampersand Capital Partners has acquired Protein Technologies, a provider of peptide synthesis instrumentation, for an undisclosed amount. “Protein Technologies is the recognized leader in a segment of the life sciences instrument market that is experiencing strong demand based on worldwide research interest in novel, peptide-based therapies,” said David Parker, general […]
Waltham, MA 4/30/15—PerkinElmer has purchased Torion Technologies, a supplier of portable GC/MS systems for analyzing chemical and biological threats, contaminants and pollutants. The company stated, “This acquisition expands PerkinElmer’s offerings to include dedicated, small-footprint analyzers for laboratory use and mobile systems for field analyses.” The acquisition closed April 30, 2015.
Woburn, MA 6/16/15—HighRes Biosolutions announced the purchase of a majority stake of the company by Axel Johnson, a privately owned investment company, for an undisclosed amount. “HighRes is expecting to double its bookings from last year, and we are on the verge of introducing some of the most exciting new products in our history,” stated […]
Waltham, MA 6/25/15; London, UK 6/25/15-—Thermo Fisher Scientific has agreed to acquire Alfa Aesar, the Research Chemicals business of Johnson Matthey, for £256 million ($400 million = £0.64 = $1) in cash. In fiscal 2015 ending March 31, the business had sales, excluding the value of precious metals, of £77 million ($124 million = £0.62 […]
Milford, MA 6/25/15—Waters has appointed Christopher J. O’Connell as president, CEO and a member of the Board, effective September 2015. Most recently, he served as president of the Restorative Therapies Group at Medtronic. Current CEO Douglas A. Berthiaume will continue to serve as chairman. “From the outset, Waters’s Board of Directors focused on identifying a […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
